The treatment of hepatitis C

di Mangia • 2017 • dettagli prodotto

spedizione gratuita
normalmente disponibile
per la spedizione in 4-6 giorni lavorativi

da €35,00 a € 29,75
accedi o registrati per vedere le promozioni a te riservate

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

Aggiungi al carrello
Aggiungi alla lista dei desideri

DESCRIZIONE

Hepatitis C virus infection is a major health problem worldwide and no vaccine is yet available against this virus. The goal of antiviral treatment in patients with chronic hepatitis C (HCV) infection is a persistent viral clearance. The achievement of this short-term outcome is the only way to ensure that, in patients with chronic liver damage, the underlying liver disease is going to stabilize and liver-related mortality to decrease. Interferon and ribavirin have represented the approved pharmacotherapies for HCV infection for many years. They were associated with suboptimal cure rates and had side effects that result in non-compliance and premature treatment discontinuation. After dominating both Infectious diseases and gastroenterologist and hepatologists’ interests for over 25 years, hepatitis C is nowadays a curable disease and its treatment represents one of the most important successes in the history of medicine.